https://www.healio.com/news/hematology-oncology/20230218/niraparib-regimen-improves-outcomes-for-men-with-prostate-cancer-hrr-gene-alterations
0
0
50 words
0
Comments
SAN FRANCISCO — The addition of niraparib to abiraterone acetate and prednisone improved multiple outcomes for certain men with metastatic castration-resistant prostate cancer, according to randomized phase 3 study results.A second interim analysis of t…
You are the first to view
Create an account or login to join the discussion